Profound Medical

Profound Medical Corp. is a medical technology company that specializes in developing magnetic resonance-guided ablation procedures for treating prostate disease, uterine fibroids, and palliative pain management. The company’s primary product, the TULSA-PRO system, integrates real-time MRI guidance with ultrasound technology to provide precise, non-invasive treatment options for various conditions. Additionally, Profound Medical offers the Sonalleve platform, which targets uterine fibroids and bone metastases, enhancing the range of therapeutic solutions available to clinicians. The company collaborates with GE Healthcare to improve access to its TULSA-PRO system in medical facilities. Headquartered in Mississauga, Canada, Profound Medical is dedicated to advancing the standard of care by enabling safe and effective treatment alternatives for patients, allowing them to return to their daily lives more quickly.